FI98215B - Förfarande för framställning av dihydropyridinderivat användbara i antitumörterapi - Google Patents

Förfarande för framställning av dihydropyridinderivat användbara i antitumörterapi

Info

Publication number
FI98215B
FI98215B FI924110A FI924110A FI98215B FI 98215 B FI98215 B FI 98215B FI 924110 A FI924110 A FI 924110A FI 924110 A FI924110 A FI 924110A FI 98215 B FI98215 B FI 98215B
Authority
FI
Finland
Prior art keywords
chem
alkoxy
group
alkyl optionally
preparation
Prior art date
Application number
FI924110A
Other languages
English (en)
Finnish (fi)
Other versions
FI924110A (sv
FI98215C (sv
FI924110A0 (sv
Inventor
Paolo Cozzi
Maria Menichincheri
Laura Capolongo
Nicola Mongelli
Original Assignee
Erba Carlo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Carlo Spa filed Critical Erba Carlo Spa
Publication of FI924110A0 publication Critical patent/FI924110A0/sv
Publication of FI924110A publication Critical patent/FI924110A/sv
Publication of FI98215B publication Critical patent/FI98215B/sv
Application granted granted Critical
Publication of FI98215C publication Critical patent/FI98215C/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
  • Saccharide Compounds (AREA)
FI924110A 1991-09-19 1992-09-14 Förfarande för framställning av dihydropyridinderivat användbara i antitumörterapi FI98215C (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9119983 1991-09-19
GB919119983A GB9119983D0 (en) 1991-09-19 1991-09-19 Dihydropyridine derivatives useful in antitumor therapy

Publications (4)

Publication Number Publication Date
FI924110A0 FI924110A0 (sv) 1992-09-14
FI924110A FI924110A (sv) 1993-03-20
FI98215B true FI98215B (sv) 1997-01-31
FI98215C FI98215C (sv) 1997-05-12

Family

ID=10701636

Family Applications (1)

Application Number Title Priority Date Filing Date
FI924110A FI98215C (sv) 1991-09-19 1992-09-14 Förfarande för framställning av dihydropyridinderivat användbara i antitumörterapi

Country Status (21)

Country Link
US (1) US5362729A (sv)
EP (1) EP0533504B1 (sv)
JP (1) JPH05213935A (sv)
KR (1) KR930006002A (sv)
AT (1) ATE148698T1 (sv)
AU (1) AU651001B2 (sv)
CA (1) CA2078606A1 (sv)
DE (1) DE69217308T2 (sv)
DK (1) DK0533504T3 (sv)
ES (1) ES2099800T3 (sv)
FI (1) FI98215C (sv)
GB (1) GB9119983D0 (sv)
GR (1) GR3022988T3 (sv)
HU (1) HUT61994A (sv)
IL (1) IL103019A (sv)
MX (1) MX9205207A (sv)
MY (1) MY129935A (sv)
NZ (1) NZ244280A (sv)
RU (1) RU2086548C1 (sv)
TW (1) TW283147B (sv)
ZA (1) ZA927115B (sv)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5508410A (en) * 1993-11-30 1996-04-16 Reilly Industries, Inc. Process for preparing 2-halo-5-substituted pyridines
US5554621A (en) * 1995-06-07 1996-09-10 Bristol-Myers Squibb Company Dihydropyridine NPY antagonists: nitrogen heterocyclic derivatives
US5668151A (en) * 1995-06-07 1997-09-16 Bristol-Myers Squibb Company Dihydropyridine NPY antagonists: piperidine derivatives
GB9515445D0 (en) * 1995-07-27 1995-09-27 Pharmacia Spa Dihydropyridine and pyridine derivatives and process for their preparation
GB2310136A (en) * 1996-02-16 1997-08-20 Pharmacia Spa Dihydropyridine derivatives as aromatase inhibitors
US5889016A (en) * 1997-06-26 1999-03-30 Bristol-Myers Squibb Company Dihydropyrimidone derivatives as NPY antagonists
ES2151850B1 (es) * 1998-10-26 2001-08-16 Esteve Quimica Sa Intermedio para la sintesis de amlodipino para su obtencion y utilizacion correspondiente.
WO2000078319A1 (en) 1999-06-21 2000-12-28 Bristol-Myers Squibb Company Dihydropyrazine derivatives as npy antagonists
US6693099B2 (en) 2000-10-17 2004-02-17 The Procter & Gamble Company Substituted piperazine compounds optionally containing a quinolyl moiety for treating multidrug resistance
US6376514B1 (en) 2000-10-17 2002-04-23 The Procter & Gamble Co. Substituted six-membered heterocyclic compounds useful for treating multidrug resistance and compositions and methods thereof
WO2010009146A1 (en) * 2008-07-15 2010-01-21 University Of Kansas Nanoclusters for delivery of poorly water soluble drug nanoparticles
US8906392B2 (en) * 2005-12-16 2014-12-09 University Of Kansas Nanocluster compositions and methods
CN103998038A (zh) 2011-11-24 2014-08-20 里皮达特发展研究及咨询公司 具有hsp调节活性的1,4-二氢吡啶衍生物
CN105175326B (zh) * 2015-08-19 2018-02-27 四川国康药业有限公司 5‑甲基‑2(1h)吡啶酮衍生物及其制备方法和用途
KR102528669B1 (ko) * 2016-06-10 2023-05-04 엘지전자 주식회사 식기 세척기

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1670827C3 (de) * 1967-03-20 1974-10-24 Bayer Ag, 5090 Leverkusen 4-(2'-Nitrophenyl)-2,6-dimethyl-3,5-dicarbmethoxy-1,4-dihydropyridin
DE2508181A1 (de) * 1975-02-26 1976-09-09 Bayer Ag 1,4-dihydropyridincarbonsaeurearal- kylester, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
SU725406A1 (ru) * 1978-08-08 1981-07-30 Ордена Трудового Красного Знамениинститут Органического Синтеза Ah Латвий-Ской Ccp Эфиры диметил дигидропиридин диКАРбОНОВОй КиСлОТы,ОблАдАющиЕ АНТи-МЕТАСТАТичЕСКОй АКТиВНОСТью
JPS58159490A (ja) * 1982-02-23 1983-09-21 Nikken Kagaku Kk １，４−ジヒドロピリジン化合物
DE3478685D1 (en) * 1983-03-04 1989-07-20 Nikken Chemicals Co Ltd 1,4-dihydropyridine compound
US4906646A (en) * 1983-03-31 1990-03-06 Board Of Governors Of Wayne State University Method and composition for the treatment of tumors by administering a platinum coordination compound and a calcium channel blocker compound of the dihydropyridine class
US4690935A (en) * 1983-03-31 1987-09-01 Wayne State University Inhibition of tumor growth and metastasis with calcium channel blocker compounds
DE3326384A1 (de) * 1983-07-22 1985-01-31 Bayer Ag, 5090 Leverkusen 1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
SU1125957A1 (ru) * 1983-10-20 1986-03-23 Ордена Трудового Красного Знамени Институт Органического Синтеза Ан Латвсср 4-(3-Метилпиразолил-4)-2,6-диметил-3,5-диэтоксикарбонил-1,4-дигидропиридин ,об ладающий гепатопротекторной активностью
IT1201454B (it) * 1985-08-19 1989-02-02 Boehringer Biochemia Srl 1,4-diidropiridine-2-sostituite
DE3601196A1 (de) * 1986-01-17 1987-07-23 Merck Patent Gmbh 1,4-dihydropyridine
IT1204459B (it) * 1986-02-20 1989-03-01 Glaxo Spa Derivati eterociclici
JPS63135381A (ja) * 1986-11-26 1988-06-07 Kyorin Pharmaceut Co Ltd 多剤耐性癌細胞に対する感受性増強剤及びその製造方法
DE3711991A1 (de) * 1987-04-09 1988-10-20 Bayer Ag Dihydropyridinamide, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
JPH02167262A (ja) * 1988-06-05 1990-06-27 Taisho Pharmaceut Co Ltd １，４―ジヒドロピリジン誘導体
DE68909873T2 (de) * 1988-07-28 1994-02-10 Nikken Chemicals Co Ltd 1,4-Dihydropyridin-Derivate.
JP2640245B2 (ja) * 1988-07-28 1997-08-13 日研化学株式会社 １，４−ジヒドロピリジン誘導体
IL92646A0 (en) * 1988-12-15 1990-08-31 Erba Carlo Spa Imidazolyl and pyridyl derivatives of phenyl substituted 1,4-dihydropyridines,their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
RU2086548C1 (ru) 1997-08-10
KR930006002A (ko) 1993-04-20
DE69217308D1 (de) 1997-03-20
MY129935A (en) 2007-05-31
DK0533504T3 (da) 1997-04-07
FI924110A (sv) 1993-03-20
HU9202934D0 (en) 1992-11-30
CA2078606A1 (en) 1993-03-20
AU2359392A (en) 1993-03-25
MX9205207A (es) 1993-03-01
NZ244280A (en) 1995-02-24
GR3022988T3 (en) 1997-07-30
IL103019A0 (en) 1993-02-21
FI98215C (sv) 1997-05-12
ES2099800T3 (es) 1997-06-01
AU651001B2 (en) 1994-07-07
DE69217308T2 (de) 1997-05-28
IL103019A (en) 1996-10-31
ATE148698T1 (de) 1997-02-15
ZA927115B (en) 1993-03-22
EP0533504B1 (en) 1997-02-05
TW283147B (sv) 1996-08-11
JPH05213935A (ja) 1993-08-24
US5362729A (en) 1994-11-08
HUT61994A (en) 1993-03-29
GB9119983D0 (en) 1991-11-06
FI924110A0 (sv) 1992-09-14
EP0533504A1 (en) 1993-03-24

Similar Documents

Publication Publication Date Title
GB9625045D0 (en) Parasiticidal compounds
FI98215B (sv) Förfarande för framställning av dihydropyridinderivat användbara i antitumörterapi
ATE119774T1 (de) Imidazopyridinderivate und ihre verwendung.
DE69919897D1 (en) 4-oxo-1,4-dihydro-3-chinolincarboxamide als antivirale mittel
HU9503930D0 (en) Substituted spiroheterocyclic 1h-3-arylpyrrolidine-2,4-dione derivatives, methods of preparing them and their use as pest-control agents
DE3781080D1 (de) 2-substituierte-e-kondensierte(1,2,4)triazolo-(1,5-c)pyrimidine, pharmazeutische zubereitungen und ihre verwendung.
NO934792L (no) Xantinderivater
BG104287A (en) Halogensubstituted tetracyclic derivatives of tetrahydrofuran
NO910804L (no) Substituerte beta-diketoner.
FR2694557B1 (fr) Dérivés de tétrahydronaphtalène, leur préparation, et leur application en thérapeutique.
CA2272136A1 (en) Pyrazole derivatives having crf antagonist activity
EP0513398A4 (en) Intermediate for synthesis of carbapenem and production of said intermediate

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed